» Articles » PMID: 21755041

Trypanosome Prereplication Machinery: a Potential New Target for an Old Problem

Overview
Journal Enzyme Res
Publisher Hindawi
Date 2011 Jul 15
PMID 21755041
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Approximately ten million people suffer from Chagas disease worldwide, caused by Trypanosoma cruzi, with the disease burden predominately focused in Latin America. Sleeping sickness is another serious health problem, caused by Trypanosoma brucei, especially in sub-Saharan countries. Unfortunately, the drugs currently available to treat these diseases have toxic effects and are not effective against all disease phases or parasite strains. Therefore, there is a clear need for the development of novel drugs and drug targets to treat these diseases. We propose the trypanosome prereplication machinery component, Orc1/Cdc6, as a potential target for drug development. In trypanosomes, Orc1/Cdc6 is involved in nuclear DNA replication, and, despite its involvement in such a conserved process, Orc1/Cdc6 is distinct from mammalian Orc1 and Cdc6 proteins. Moreover, RNAi-mediated silencing of trypanosome Orc1/Cdc6 expression in T. brucei decreased cell survival, indicating that Orc1/Cdc6 is critical for trypanosome survival.

Citing Articles

Extensive Translational Regulation through the Proliferative Transition of Trypanosoma cruzi Revealed by Multi-Omics.

Chavez S, Urbaniak M, Benz C, Smircich P, Garat B, Sotelo-Silveira J mSphere. 2021; 6(5):e0036621.

PMID: 34468164 PMC: 8550152. DOI: 10.1128/mSphere.00366-21.


DNA replication protein Cdc45 directly interacts with PCNA via its PIP box in Leishmania donovani and the Cdc45 PIP box is essential for cell survival.

Yadav A, Sharma V, Pal J, Gulati P, Goel M, Chandra U PLoS Pathog. 2020; 16(5):e1008190.

PMID: 32413071 PMC: 7255605. DOI: 10.1371/journal.ppat.1008190.


Conservation and Variation in Strategies for DNA Replication of Kinetoplastid Nuclear Genomes.

Marques C, McCulloch R Curr Genomics. 2018; 19(2):98-109.

PMID: 29491738 PMC: 5814967. DOI: 10.2174/1389202918666170815144627.


The origin recognition complex in human diseases.

Shen Z Biosci Rep. 2013; 33(3).

PMID: 23662735 PMC: 3679595. DOI: 10.1042/BSR20130036.

References
1.
Apt W . Current and developing therapeutic agents in the treatment of Chagas disease. Drug Des Devel Ther. 2010; 4:243-53. PMC: 2948934. DOI: 10.2147/dddt.s8338. View

2.
Magnus E, Vervoort T, VAN MEIRVENNE N . A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T. B. gambiense trypanosomiasis. Ann Soc Belg Med Trop. 1978; 58(3):169-76. View

3.
Bell S, Stillman B . ATP-dependent recognition of eukaryotic origins of DNA replication by a multiprotein complex. Nature. 1992; 357(6374):128-34. DOI: 10.1038/357128a0. View

4.
DUGGAN A, HUTCHINSON M . Sleeping sickness in Europeans: a review of 109 cases. J Trop Med Hyg. 1966; 69(6):124-31. View

5.
Russomando G, de Tomassone M, De Guillen I, Acosta N, Vera N, Almiron M . Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg. 1998; 59(3):487-91. DOI: 10.4269/ajtmh.1998.59.487. View